Atlas Biologics, LLC
Publicly observedState College, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | State College | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Atlas Biologics, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | N1CDHMCWRXF5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jun 2024Publicly observed
NIH SBIR/STTR award: Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
USD 1,000,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jun 2024Publicly observed
NIH SBIR/STTR award: Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
USD 1,000,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.